Ralph Venhaus

Ralph Venhaus

UNVERIFIED PROFILE

Are you Ralph Venhaus?   Register this Author

Register author
Ralph Venhaus

Ralph Venhaus

Publications by authors named "Ralph Venhaus"

Are you Ralph Venhaus?   Register this Author

15Publications

633Reads

31Profile Views

Safety and efficacy of the antiganglioside GD3 antibody ecromeximab (KW2871) combined with high-dose interferon-α2b in patients with metastatic melanoma.

Melanoma Res 2017 08;27(4):342-350

aDepartment of Medicine, Division of Hematology and Oncology, University of Pittsburgh, Pittsburgh, Pennsylvania bLudwig Institute for Cancer Research Ltd, New York, New York cDepartment of Medicine, Section of Hematology/Oncology, The University of Chicago, Chicago, Illinois, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CMR.0000000000000353DOI Listing
August 2017

NY-ESO-1 Protein Cancer Vaccine With Poly-ICLC and OK-432: Rapid and Strong Induction of NY-ESO-1-specific Immune Responses by Poly-ICLC.

J Immunother 2017 Mar 23. Epub 2017 Mar 23.

*Department of Gastroenterological Surgery †Clinical Research in Tumor Immunology, Graduate School of Medicine, Osaka University, Suita ∥Department of Tumor Immunology, Drug Discovery and Disease Research Laboratory, Shionogi and Co. Ltd, Osaka ‡Department of Respiratory Medicine, Kawasaki Medical School **Faculty of Health and Welfare, Kawasaki University of Medical Welfare, Kurashiki, Okayama §Department of Pathology, Tokyo Medical University, Shinjuku-ku, Tokyo ¶Department of Immunology, Nagoya University Graduate School of Medicine, Nagoya, Aichi, Japan #Ludwig Institute for Cancer Research, New York, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CJI.0000000000000162DOI Listing
March 2017

Phase I Imaging and Pharmacodynamic Trial of CS-1008 in Patients With Metastatic Colorectal Cancer.

J Clin Oncol 2015 Aug 29;33(24):2609-16. Epub 2015 Jun 29.

Marika Ciprotti, Niall C. Tebbutt, Fook-Thean Lee, Sze-Ting Lee, Hui K. Gan, Wendie Hopkins, Fiona E. Scott, Andrew M. Scott, Ludwig Institute for Cancer Research; David C. McKee, Graeme J. O'Keefe, Sylvia J. Gong, Geoffrey Chong, Bridget Chappell, Andrew M. Scott, Austin Health, Melbourne, Australia; Martin W. Brechbiel, National Cancer Institute, Bethesda, MD; Archie N. Tse, Jonathan Greenberg, Daiichi Sankyo Co., Ltd, Parsippany, NJ; Mendel Jansen, Daiichi Sankyo Development Ltd, Gerrards Cross, Buckinghamshire, United Kingdom; Manabu Matsumura, Masakatsu Kotsuma, Rira Watanabe, Daiichi Sankyo Co., Ltd, Tokyo, Japan; Robert A. Beckman, Georgetown University Medical Center and Ralph Venhaus, Ludwig Institute for Cancer Research, New York, NY.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2014.60.4256
Publisher Site
http://dx.doi.org/10.1200/JCO.2014.60.4256DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4881374PMC
August 2015

Vaccination with NY-ESO-1 overlapping peptides mixed with Picibanil OK-432 and montanide ISA-51 in patients with cancers expressing the NY-ESO-1 antigen.

J Immunother 2014 Feb-Mar;37(2):84-92

*Department of Gastroenterological Surgery, Graduate School of Medicine ‡‡Experimental Immunology, Immunology Frontier Research Center, Osaka University, Suita, Osaka †Department of Respiratory Medicine, Kawasaki Medical School ∥∥Faculty of Health and Welfare, Kawasaki University of Medical Welfare, Kurashiki Departments of ∥Medicine ¶Dermatology #Immunology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Okayama Departments of ‡Immunotherapeutics **Gastrointestinal Surgery, University of Tokyo Hospital, Bunkyo-ku §Department of Pathology, Tokyo Medical University, Shinjuku-ku ††Department of Gastroenterological Surgery, The Cancer Institute Hospital, Koto-ku, Tokyo, Japan §§Ludwig Institute for Cancer Research, New York, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CJI.0000000000000017DOI Listing
October 2014

Regulatory T-cell-mediated attenuation of T-cell responses to the NY-ESO-1 ISCOMATRIX vaccine in patients with advanced malignant melanoma.

Clin Cancer Res 2009 Mar 10;15(6):2166-73. Epub 2009 Mar 10.

Ludwig Institute for Cancer Research, Austin Health, Peter MacCallum Cancer Centre, CSL Limited, Melbourne, Victoria, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-08-2484DOI Listing
March 2009